CA2651634C - Substituted piperidino phenyloxazolidinones - Google Patents

Substituted piperidino phenyloxazolidinones Download PDF

Info

Publication number
CA2651634C
CA2651634C CA2651634A CA2651634A CA2651634C CA 2651634 C CA2651634 C CA 2651634C CA 2651634 A CA2651634 A CA 2651634A CA 2651634 A CA2651634 A CA 2651634A CA 2651634 C CA2651634 C CA 2651634C
Authority
CA
Canada
Prior art keywords
compound
formula
pharmaceutically acceptable
compounds
acetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2651634A
Other languages
English (en)
French (fr)
Other versions
CA2651634A1 (en
Inventor
Mahesh Vithalbhai Patel
Mahesh Phansalkar
Vijaykumar Jagdishwar Patil
Milind Dattatraya Sindkhedkar
Prasad Keshav Deshpande
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wockhardt Ltd
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of CA2651634A1 publication Critical patent/CA2651634A1/en
Application granted granted Critical
Publication of CA2651634C publication Critical patent/CA2651634C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D8/00—Methods for preparing or baking dough
    • A21D8/02—Methods for preparing dough; Treating dough prior to baking
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B6/00—Heating by electric, magnetic or electromagnetic fields
    • H05B6/02—Induction heating
    • H05B6/10—Induction heating apparatus, other than furnaces, for specific applications
    • H05B6/12—Cooking devices

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Electromagnetism (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CA2651634A 2006-05-09 2007-05-08 Substituted piperidino phenyloxazolidinones Expired - Fee Related CA2651634C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN719/MUM/2006 2006-05-09
IN719MU2006 2006-05-09
PCT/IB2007/001179 WO2007132314A2 (en) 2006-05-09 2007-05-08 Substituted piperidino phenyloxazolidinones

Publications (2)

Publication Number Publication Date
CA2651634A1 CA2651634A1 (en) 2007-11-22
CA2651634C true CA2651634C (en) 2013-07-30

Family

ID=38694273

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2651634A Expired - Fee Related CA2651634C (en) 2006-05-09 2007-05-08 Substituted piperidino phenyloxazolidinones

Country Status (13)

Country Link
US (1) US8217058B2 (enExample)
EP (1) EP2018792B1 (enExample)
JP (1) JP5313126B2 (enExample)
KR (1) KR101345445B1 (enExample)
CN (1) CN102106184B (enExample)
AU (1) AU2007251289A1 (enExample)
BR (1) BRPI0712535A2 (enExample)
CA (1) CA2651634C (enExample)
ES (1) ES2556183T3 (enExample)
MX (1) MX2008013371A (enExample)
RU (1) RU2008148319A (enExample)
WO (1) WO2007132314A2 (enExample)
ZA (1) ZA200809724B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687627B2 (en) * 2003-09-08 2010-03-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
US8217058B2 (en) * 2006-05-09 2012-07-10 Wockhardt Ltd. Substituted piperidino phenyloxazolidinones
CN101616588B (zh) 2006-09-25 2013-09-25 沃克哈特研究中心 取代的哌啶子基苯基噁唑烷酮
CN103391943A (zh) * 2010-11-03 2013-11-13 沃克哈特有限公司 磷酸单-(1-{4-[(s)-5-(乙酰基氨基-甲基)-2-氧代-噁唑烷-3-基]-2,6-二氟苯基}-4-甲氧基甲基-哌啶-4-基)酯的制备方法
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide
WO2018048882A1 (en) 2016-09-06 2018-03-15 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for bacterial infection
WO2023209678A1 (en) * 2022-04-29 2023-11-02 Zenal Pharmachem Llc Aryl azo pyrazole derivatives as antimicrobial agent
WO2023209677A2 (en) * 2022-04-29 2023-11-02 Zenal Pharmachem Llc A novel aryl azo pyrazole compound and its synthesis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668285A (en) 1986-10-31 1997-09-16 The United States Of America As Represented By The Department Of Health And Human Services Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
US5668286A (en) * 1994-03-15 1997-09-16 Pharmacia & Upjohn Company Oxazolidinone derivatives and pharmaceutical compositions containing them
JPH0873455A (ja) * 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
CA2492194A1 (en) * 2002-07-11 2004-01-22 Wockhardt Limited Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoproteins sites
US7687627B2 (en) * 2003-09-08 2010-03-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
WO2007023507A2 (en) * 2005-06-20 2007-03-01 Wockhardt Limited Oxazolidinones bearing antimicrobial activity composition and methods of preparation
US8217058B2 (en) * 2006-05-09 2012-07-10 Wockhardt Ltd. Substituted piperidino phenyloxazolidinones

Also Published As

Publication number Publication date
US8217058B2 (en) 2012-07-10
JP5313126B2 (ja) 2013-10-09
WO2007132314A3 (en) 2011-07-14
AU2007251289A1 (en) 2007-11-22
ZA200809724B (en) 2011-10-26
JP2009536939A (ja) 2009-10-22
EP2018792B1 (en) 2015-09-16
KR20090028699A (ko) 2009-03-19
EP2018792A2 (en) 2009-01-28
EP2018792A4 (en) 2012-12-05
MX2008013371A (es) 2009-02-06
CA2651634A1 (en) 2007-11-22
CN102106184B (zh) 2014-04-09
RU2008148319A (ru) 2010-06-20
US20100056581A1 (en) 2010-03-04
CN102106184A (zh) 2011-06-22
WO2007132314A2 (en) 2007-11-22
BRPI0712535A2 (pt) 2012-09-04
KR101345445B1 (ko) 2013-12-27
ES2556183T3 (es) 2016-01-13

Similar Documents

Publication Publication Date Title
CA2651634C (en) Substituted piperidino phenyloxazolidinones
US6605609B2 (en) Thizaine oxazolidinone
JP3628329B2 (ja) オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
AU698699B2 (en) Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
SK282453B6 (sk) Fenyloxazolidinóny
JP2000204084A (ja) チオカルバミド酸誘導体
US7012088B2 (en) Indolone oxazolidinones and derivatives thereof
US20040254162A1 (en) Oxazolidinone derivatives as antimicrobials
JP4917432B2 (ja) インビボ効力が改良された抗菌活性を有する置換ピペリジノフェニルオキサゾリジノン化合物
JPH11322729A (ja) ジチオカルバミド酸誘導体
US6927229B2 (en) Difluorothioacetamides of oxazolidinones as antibacterial agents
WO2005113520A1 (en) Substituted 2,3,5-trifluorphenyl oxazolidinones for use as antibacterial agents
US20090137553A1 (en) Thiazepine Oxazolidinones as Antibacterial Agents
EP1902048A1 (en) Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents
WO2004007488A2 (en) Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them
US7435751B2 (en) 7-Fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
US20040072842A1 (en) Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
JP2008521792A (ja) 抗菌薬としてのジアゼピンオキサゾリジノン
US20060229348A1 (en) Oxindole oxazolidinone as antibacterial agent
PL190431B1 (pl) Pochodne oksazolidynonów, ich zastosowanie i kompozycja farmaceutyczna je zawierająca

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20200831